| scholarly article | Q13442814 |
| P2093 | author name string | P S Moore | |
| Y Chang | |||
| R Sarid | |||
| J S Wiezorek | |||
| P2860 | cites work | IRF-7, a New Interferon Regulatory Factor Associated with Epstein-Barr Virus Latency | Q24315695 |
| Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma | Q27636336 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Direct role for Myc in transcription initiation mediated by interactions with TFII-I | Q28262704 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Expression of Human Herpesvirus 8-Encoded Cyclin D in Kaposi's Sarcoma Spindle Cells | Q32163310 | ||
| A new class of reversible cell cycle inhibitors | Q33383874 | ||
| A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus | Q33784966 | ||
| Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus | Q33965965 | ||
| Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) | Q34069105 | ||
| Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. | Q34294106 | ||
| Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions | Q34295503 | ||
| Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
| Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
| Epstein-Barr virus mRNAs produced by alternative splicing | Q35051384 | ||
| Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease | Q35764989 | ||
| Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma | Q35872949 | ||
| Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. | Q35874857 | ||
| Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma | Q35892261 | ||
| Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis | Q35990527 | ||
| A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells | Q36015363 | ||
| Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency | Q36648185 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. | Q37693393 | ||
| The Epstein-Barr Virus Immediate-Early Gene Product, BRLF1, Interacts with the Retinoblastoma Protein during the Viral Lytic Cycle | Q38333491 | ||
| Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells | Q39580911 | ||
| Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP | Q39876911 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. | Q39878517 | ||
| The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. | Q39879780 | ||
| Epstein-Barr virus strategy in normal and neoplastic B cells | Q40657378 | ||
| EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. | Q40792597 | ||
| In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences | Q40971183 | ||
| How viral oncogenes make the cell cycle | Q41078321 | ||
| Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. | Q41079253 | ||
| Effect of DNA Synthesis Inhibitors on Kaposi's Sarcoma-Associated Herpesvirus Cyclin and Major Capsid Protein Gene Expression | Q41089658 | ||
| Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
| Virus-encoded cyclin | Q41431627 | ||
| Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 | ||
| Cyclin encoded by KS herpesvirus | Q42633290 | ||
| The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus | Q45788440 | ||
| p14ARF links the tumour suppressors RB and p53 | Q55067966 | ||
| Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV | Q56999790 | ||
| TFII is required for transcription of the naturally TATA-less but initiator-containing Vbeta promoter | Q71142774 | ||
| P433 | issue | 2 | |
| P921 | main subject | Kaposi's sarcoma-associated herpesvirus | Q983850 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1438-1446 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter | |
| P478 | volume | 73 |
| Q35791222 | A cluster of transcripts encoded by KSHV ORF30-33 gene locus |
| Q33815534 | A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. |
| Q37523519 | A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication |
| Q37308761 | A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection |
| Q35123088 | Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen |
| Q35056440 | Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. |
| Q33843421 | Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). |
| Q35868064 | An Alternative Kaposi's Sarcoma-Associated Herpesvirus Replication Program Triggered by Host Cell Apoptosis |
| Q40344541 | An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame. |
| Q33809466 | Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri |
| Q39729318 | Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus |
| Q36559926 | CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming |
| Q39860615 | Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions |
| Q34340317 | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR |
| Q58700278 | Circular DNA tumor viruses make circular RNAs |
| Q40020777 | Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators |
| Q40267788 | Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression |
| Q38097263 | Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies |
| Q34331772 | Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions |
| Q39602154 | Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters |
| Q41891421 | Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus |
| Q42931199 | ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection |
| Q38727204 | Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus |
| Q35185898 | Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. |
| Q37060535 | Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program |
| Q34717873 | Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster |
| Q34782463 | Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator |
| Q33683742 | Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. |
| Q39593823 | Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity |
| Q35787282 | High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma |
| Q33295395 | Host transcript accumulation during lytic KSHV infection reveals several classes of host responses |
| Q38156891 | How virus persistence can initiate the tumorigenesis process |
| Q92128486 | Human DNA Virus Exploitation of the MAPK-ERK Cascade |
| Q35788580 | Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor |
| Q24527215 | Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells |
| Q36817675 | Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions. |
| Q37383464 | Identification of an Rta responsive promoter involved in driving gammaHV68 v-cyclin expression during virus replication |
| Q34353305 | Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection |
| Q33815257 | Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus |
| Q41901560 | Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue |
| Q36433852 | Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. |
| Q41886930 | Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells |
| Q37410861 | Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q39819343 | Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression |
| Q35665756 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors |
| Q39265271 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence |
| Q39611761 | Kaposi's Sarcoma-Associated Herpesvirus-Induced Angiogenin Plays Roles in Latency via the Phospholipase Cγ Pathway: Blocking Angiogenin Inhibits Latent Gene Expression and Induces the Lytic Cycle |
| Q29394711 | Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? |
| Q41846091 | Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation |
| Q33834993 | Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 |
| Q40040603 | Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications |
| Q38305362 | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q47560895 | Kaposi’s sarcoma: a computational approach through protein–protein interaction and gene regulatory networks analysis |
| Q34276926 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha. |
| Q35363036 | Mechanism of Glycyrrhizic Acid Inhibition of Kaposi's Sarcoma-Associated Herpesvirus: Disruption of CTCF-Cohesin-Mediated RNA Polymerase II Pausing and Sister Chromatid Cohesion |
| Q38915526 | Mechanism of angiopoietin-1 upregulation in Kaposi's sarcoma-associated herpesvirus-infected PEL cell lines |
| Q39602182 | Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q28363323 | Molecular virology of Kaposi's sarcoma-associated herpesvirus |
| Q37374081 | NF-κB as a Target for Oncogenic Viruses |
| Q37336869 | Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque. |
| Q37252928 | Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency. |
| Q34333321 | Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus |
| Q33820704 | Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen |
| Q36736361 | Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells |
| Q24538878 | Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes |
| Q37727998 | Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells |
| Q60952467 | Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter |
| Q51791992 | Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. |
| Q33906970 | Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases |
| Q35125136 | Split genes and their expression in Kaposi's sarcoma‐associated herpesvirus |
| Q34291542 | Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products |
| Q35124429 | Structure and function of latency-associated nuclear antigen |
| Q34359241 | Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction |
| Q35635202 | Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus |
| Q34355898 | The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. |
| Q34359380 | The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter |
| Q34977304 | The Latency-Associated Nuclear Antigen Homolog of Herpesvirus Saimiri Inhibits Lytic Virus Replication |
| Q39592670 | The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. |
| Q37252776 | The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
| Q34349469 | Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice |
| Q33227754 | Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region |
| Q34434808 | Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs |
| Q34351693 | Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus |
| Q39612361 | Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene |
| Q39612221 | Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. |
| Q34411851 | Unbiased Mutagenesis of MHV68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo |
| Q24799552 | Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis |
| Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
| Q37811898 | Why do viruses cause cancer? Highlights of the first century of human tumour virology |
Search more.